The Roles of Frequently Mutated Genes of Pancreatic Cancer in Regulation of Tumor Microenvironment
Authors:
Open Access
- 1 January 2020
- journal article
- research article
- Published by SAGE Publications in Technology in Cancer Research & Treatment
- Vol. 19
Abstract
Pancreatic ductal adenocarcinoma has extremely high malignancy and patients with pancreatic ductal adenocarcinoma have dismal prognosis. The failure of pancreatic ductal adenocarcinoma treatment is largely due to the tumor microenvironment, which is featured by ample stromal cells and complicated extracellular matrix. Recent genomic analysis revealed that pancreatic ductal adenocarcinoma harbors frequently mutated genes including KRAS, TP53, CDKN2A, and SMAD4, which can widely alter cellular processes and behaviors. As shown by accumulating studies, these mutant genes may also change tumor microenvironment, which in turn affects pancreatic ductal adenocarcinoma progression. In this review, we summarize the role of such genetic mutations in tumor microenvironment regulation and potential mechanisms.Keywords
This publication has 61 references indexed in Scilit:
- CTGF antagonism with mAb FG-3019 enhances chemotherapy response without increasing drug delivery in murine ductal pancreas cancerProceedings of the National Academy of Sciences, 2013
- Exploiting inflammation for therapeutic gain in pancreatic cancerBritish Journal of Cancer, 2013
- Ras trafficking, localization and compartmentalized signallingSeminars in Cell & Developmental Biology, 2012
- RAS oncogenes: weaving a tumorigenic webNature Reviews Cancer, 2011
- The Unholy Trinity: Inflammation, Cytokines, and STAT3 Shape The Cancer MicroenvironmentCancer Cell, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Phenotypic changes in mouse pancreatic stellate cell Ca2+ signaling events following activation in culture and in a disease model of pancreatitisMolecular Biology of the Cell, 2011
- Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen–specific CD8+ T cell dysfunction in melanoma patientsJournal of Experimental Medicine, 2010
- A Genome-wide RNAi Screen Identifies Multiple Synthetic Lethal Interactions with the Ras OncogeneCell, 2009
- The Ras-RasGAP Complex: Structural Basis for GTPase Activation and Its Loss in Oncogenic Ras MutantsScience, 1997